Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
J Exp Clin Cancer Res. 2020 Feb 5;39(1):29. doi: 10.1186/s13046-020-1536-x.
J Exp Clin Cancer Res. 2020.
PMID: 32024543
Free PMC article.